ICH Q12 and Pharmaceutical Lifecycle Management: What Companies Need to Know About Post-Approval Changes
Nearly seven years after its finalization by the ICH Assembly in November 2019, ICH Q12 (Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management) has officially moved from a forward-looking conceptual framework to an operational regulatory expectation. With the FDA advancing its implementation, the EU clearing legal pathways through Regulation (EU) 2024/1701, and...
0 Yorumlar 0 hisse senetleri 8 Views 0 önizleme